A. Daniels

发表

Chapter 7 – Peptide antagonists of neuropeptide Y: Design, structure and pharmacological characterization

A. Spaltenstein, A. Daniels, D. Heyer, 1997 .

Mechanisms of Toxicity and Cellular Resistance to 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine and 1‐Methyl‐4‐Phenylpyridinium in Adrenomedullary Chromaffin Cell Cultures

S. Carmichael, J. Reinhard, A. Daniels, 1990, Journal of neurochemistry.

Characterization of Cellular Transport, Subcellular Distribution, and Secretion of the Neurotoxicant 1‐Methyl‐4‐Phenylpyridinium in Bovine Adrenomedullary Cell Cultures

E. Diliberto, J. Reinhard, A. Daniels, 1989, Journal of neurochemistry.

Food intake inhibition and reduction in body weight gain in lean and obese rodents treated with GW438014A, a potent and selective NPY-Y5 receptor antagonist

A. Daniels, D. Heyer, M. Grizzle, 2002, Regulatory Peptides.

Analysis of the inhibitory effect of verapamil on adrenal medullary secretion.

A. Daniels, L. Arqueros, 1978, Life sciences.

Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells.

O. H. Viveros, E. Diliberto, J. Reinhard, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Diethyldithiocarbamate Potentiates the Neurotoxicity of In Vivo l‐Methyl‐4‐Phenyl‐1, 2, 3, 6‐Tetrahydropyridine and of In Vitro 1‐Methyl‐4‐Phenylpyridinium

J. O'Callaghan, D. Miller, J. Reinhard, 1991, Journal of neurochemistry.

Carrier-independent entry of 1-methyl-4-phenylpyridinium (MPP+) into adrenal chromaffin cells as a consequence of charge delocalization.

G. Painter, J. Reinhard, A. Daniels, 1990, Biochemical and biophysical research communications.

Structure-activity relationship of novel pentapeptide neuropeptide Y receptor antagonists is consistent with a noncontinuous epitope for ligand-receptor binding.

J. Leban, O. H. Viveros, A. Daniels, 1995, Molecular pharmacology.

Energy-driven uptake of the neurotoxin 1-methyl-4-phenylpyridinium into chromaffin granules via the catecholamine transporter.

J. Reinhard, A. Daniels, 1988, The Journal of biological chemistry.

High-affinity neuropeptide Y receptor antagonists.

J. Leban, O. H. Viveros, A. Spaltenstein, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Activity of dynorphin-like peptides on neuropeptide Y receptors

J. Leban, A. Daniels, D. Heyer, 1992 .

The role of neuropeptide Y in the ovine fetal cardiovascular response to reduced oxygenation

D. Giussani, M. Seron-Ferre, A. J. W. Fletcher, 2003, The Journal of physiology.

Neuropeptide Y mobilizes intracellular Ca2+ and increases inositol phosphate production in human erythroleukemia cells.

E. Lapetina, E. Lazarowski, A. Daniels, 1989, Biochemical and biophysical research communications.

Uptake of Magnesium by Chromaffin Granules In Vitro: Role of the Proton Electrochemical Gradient

J. Fiedler, A. Daniels, 1984, Journal of neurochemistry.

Multicompartmental secretion of ascorbate and its dual role in dopamine beta-hydroxylation.

O. H. Viveros, E. Diliberto, A. Daniels, 1991, The American journal of clinical nutrition.

Secretion of newly taken-up ascorbic acid by adrenomedullary chromaffin cells.

O. H. Viveros, E. Diliberto, A. Daniels, 1982, Science.

Hemodynamic characterization of a novel neuropeptide Y receptor antagonist.

J. Leban, A. Spaltenstein, A. Daniels, 1996, Journal of cardiovascular pharmacology.

Adrenomedullary Chromaffin Cells as a Model to Study the Neurobiology of Ascorbic Acid: From Monooxygenation to Neuromodulation

F. Menniti, J. Kizer, O. H. Viveros, 1987, Annals of the New York Academy of Sciences.

The character of the stored molecules in chromaffin granules of the adrenal medulla: A nuclear magnetic resonance study

R. J. P. Williams, P. Wright, A. J. Daniels, 1978, Neuroscience.

Biochemical and functional evidence for the cosecretion of multiple messengers from single and multiple compartments.

O. H. Viveros, E. Diliberto, A. Daniels, 1983, Federation proceedings.

Characterization of ascorbic acid transport by adrenomedullary chromaffin cells. Evidence for Na+-dependent co-transport.

E. Diliberto, A. Daniels, G. Heckman, 1983, The Journal of biological chemistry.

Secretion of newly taken up ascorbic acid by adrenomedullary chromaffin cells originates from a compartment different from the catecholamine storage vesicle.

O. H. Viveros, E. Diliberto, A. Daniels, 1983, Molecular pharmacology.

Effect of intranigral Mn2+ on striatal and nigral synthesis and levels of dopamine and cofactor.

A. Daniels, J. Abarca, 1991, Neurotoxicology and teratology.

Rat striatal dopamine and tetrahydrobiopterin content following an intrastriatal injection of manganese chloride.

A. Daniels, A. Lista, J. Abarca, 1986, Life sciences.

Uptake and release of manganese by rat striatal slices.

K. Gysling, A. Daniels, J. Abarca, 1981, Biochemical pharmacology.

Manganese as agonist and antagonist of calcium ions: dual effect upon catecholamine release from adrenal medulla.

A. Daniels, L. Arqueros, 1981, Life sciences.

Synthesis, structure and stability of novel dimeric peptide-disulfides.

J. Leban, A. Aulabaugh, A. Spaltenstein, 2009, International journal of peptide and protein research.

A concise synthesis of 1,4-dihydro-[1,4]diazepine-5,7-dione, a novel 7-TM receptor ligand core structure with melanocortin receptor agonist activity.

C. Laudeman, J. Szewczyk, D. Ignar, 2010, Bioorganic & medicinal chemistry.

Regulation of Adrenocortical Guanosine Triphosphate Cyclohydrolase and Tetrahydrobiopterin in Normal and Spontaneously Hypertensive Rats

O. H. Viveros, M. Abou-donia, A. Daniels, 1983 .

Potentiation by reserpine and tetrabenazine of brain catecholamine depletions by MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) in the mouse; evidence for subcellular sequestration as basis for cellular resistance to the toxicant

J. Reinhard, A. Daniels, O.Humberto Viveros, 1988, Neuroscience Letters.

Discovery of small molecule agonists for the bombesin receptor subtype 3 (BRS-3) based on an omeprazole lead.

A. Goetz, C. Laudeman, J. Szewczyk, 2008, Bioorganic & medicinal chemistry letters.

Pharmacological characterization and selectivity of the NPY antagonist GR231118 (1229U91) for different NPY receptors

K. Koller, A. Daniels, R. Cox, 1997, Regulatory Peptides.

Novel modified carboxy terminal fragments of neuropeptide Y with high affinity for Y2-type receptors and potent functional antagonism at a Y1-type receptor.

J. Leban, A. Aulabaugh, A. Landavazo, 1995, Journal of medicinal chemistry.

Evidence in female rhesus monkeys (Macaca mulatta) that nighttime caloric intake is not associated with weight gain.

J. Cameron, E. Sullivan, A. Daniels, 2005, Obesity research.

Neuropeptide Y Y5 receptors inhibit kindling acquisition in rats

M. Gobbi, A. Vezzani, A. Beck‐Sickinger, 2005, Regulatory Peptides.

Intraneuronal Site of Action for Imipramine in Rat Striatal Slices

K. Gysling, A. Daniels, L. Arqueros, 1980, Journal of neurochemistry.

Subcellular Compartmentation of 2′Methyl MPP+ Can Explain Differences in Toxicity to Adrenal Chromaffin Cells

J. Reinhard, A. Daniels, 1992, Annals of the New York Academy of Sciences.

Accumulation of 1-methyl-4-phenylpyridinium (MPP+) into bovine chromaffin granules results in a large restriction of its molecular motion: a 13C and 31P NMR study.

G. Painter, J. Reinhard, A. Daniels, 1988, Biochemical and Biophysical Research Communications - BBRC.

Differences in the reserpine-sensitive storage in vivo of 1-methyl-4-phenylpyridinium in rats and mice may explain differences in catecholamine toxicity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

O. H. Viveros, J. Reinhard, A. Daniels, 1994, Neurotoxicology and teratology.

Characterization of the neuropeptide Y-induced intracellular calcium release in human erythroleukemic cells.

E. Lazarowski, A. Daniels, J. Matthews, 1992, Molecular pharmacology.

Discovery of small molecule agonists for the bombesin receptor subtype 3 (BRS-3) based on an omeprazole lead.

A. Goetz, C. Laudeman, J. Szewczyk, 2008, Bioorganic & medicinal chemistry letters.